Pharmacological and Nonpharmacological Interventions for Cognitive Impairment and Dementia Related to Type 2 Diabetes and Metabolic Disturbances in Aging

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Abstract

Few pharmacological interventions are available for the management of dementia in general, and to date none modify the underlying disease process. Similarly, no treatments are currently available that target cognitive impairment in individuals with type 2 diabetes mellitus (T2D). However, there have been a number of clinical trials and observational studies that can guide potential future avenues of investigation. Blood pressure-lowering and certain glucose-lowering drugs may have some therapeutic benefit in reducing the risk for cognitive impairment but conclusive evidence is lacking. Nonpharmacological interventions such as diet and exercise also show potential benefits. Because of the potentially large number of mechanisms through which T2D contributes to cognitive impairment, multimodal interventions targeting many pathways simultaneously may hold the most promise.

Original languageEnglish
Title of host publicationType 2 Diabetes and Dementia
EditorsVelandai Srikanth, Zoe Arvanitakis
Place of PublicationUnited Kingdom
PublisherAcademic Press
Chapter12
Pages231-253
Number of pages23
ISBN (Electronic)9780128096949
ISBN (Print)9780128094549
DOIs
Publication statusPublished - 6 Mar 2018

Keywords

  • Cognition
  • Dementia
  • Nonpharmacological
  • Pharmacological
  • Type 2 diabetes

Cite this

Callisaya, Michele ; Moran, Chris. / Pharmacological and Nonpharmacological Interventions for Cognitive Impairment and Dementia Related to Type 2 Diabetes and Metabolic Disturbances in Aging. Type 2 Diabetes and Dementia. editor / Velandai Srikanth ; Zoe Arvanitakis. United Kingdom : Academic Press, 2018. pp. 231-253
@inbook{7a711818d9af47259ce46a6ba011ced8,
title = "Pharmacological and Nonpharmacological Interventions for Cognitive Impairment and Dementia Related to Type 2 Diabetes and Metabolic Disturbances in Aging",
abstract = "Few pharmacological interventions are available for the management of dementia in general, and to date none modify the underlying disease process. Similarly, no treatments are currently available that target cognitive impairment in individuals with type 2 diabetes mellitus (T2D). However, there have been a number of clinical trials and observational studies that can guide potential future avenues of investigation. Blood pressure-lowering and certain glucose-lowering drugs may have some therapeutic benefit in reducing the risk for cognitive impairment but conclusive evidence is lacking. Nonpharmacological interventions such as diet and exercise also show potential benefits. Because of the potentially large number of mechanisms through which T2D contributes to cognitive impairment, multimodal interventions targeting many pathways simultaneously may hold the most promise.",
keywords = "Cognition, Dementia, Nonpharmacological, Pharmacological, Type 2 diabetes",
author = "Michele Callisaya and Chris Moran",
year = "2018",
month = "3",
day = "6",
doi = "10.1016/B978-0-12-809454-9.00012-3",
language = "English",
isbn = "9780128094549",
pages = "231--253",
editor = "Srikanth, {Velandai } and Arvanitakis, {Zoe }",
booktitle = "Type 2 Diabetes and Dementia",
publisher = "Academic Press",
address = "United States",

}

Pharmacological and Nonpharmacological Interventions for Cognitive Impairment and Dementia Related to Type 2 Diabetes and Metabolic Disturbances in Aging. / Callisaya, Michele; Moran, Chris.

Type 2 Diabetes and Dementia. ed. / Velandai Srikanth; Zoe Arvanitakis. United Kingdom : Academic Press, 2018. p. 231-253.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

TY - CHAP

T1 - Pharmacological and Nonpharmacological Interventions for Cognitive Impairment and Dementia Related to Type 2 Diabetes and Metabolic Disturbances in Aging

AU - Callisaya, Michele

AU - Moran, Chris

PY - 2018/3/6

Y1 - 2018/3/6

N2 - Few pharmacological interventions are available for the management of dementia in general, and to date none modify the underlying disease process. Similarly, no treatments are currently available that target cognitive impairment in individuals with type 2 diabetes mellitus (T2D). However, there have been a number of clinical trials and observational studies that can guide potential future avenues of investigation. Blood pressure-lowering and certain glucose-lowering drugs may have some therapeutic benefit in reducing the risk for cognitive impairment but conclusive evidence is lacking. Nonpharmacological interventions such as diet and exercise also show potential benefits. Because of the potentially large number of mechanisms through which T2D contributes to cognitive impairment, multimodal interventions targeting many pathways simultaneously may hold the most promise.

AB - Few pharmacological interventions are available for the management of dementia in general, and to date none modify the underlying disease process. Similarly, no treatments are currently available that target cognitive impairment in individuals with type 2 diabetes mellitus (T2D). However, there have been a number of clinical trials and observational studies that can guide potential future avenues of investigation. Blood pressure-lowering and certain glucose-lowering drugs may have some therapeutic benefit in reducing the risk for cognitive impairment but conclusive evidence is lacking. Nonpharmacological interventions such as diet and exercise also show potential benefits. Because of the potentially large number of mechanisms through which T2D contributes to cognitive impairment, multimodal interventions targeting many pathways simultaneously may hold the most promise.

KW - Cognition

KW - Dementia

KW - Nonpharmacological

KW - Pharmacological

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85047329765&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-809454-9.00012-3

DO - 10.1016/B978-0-12-809454-9.00012-3

M3 - Chapter (Book)

SN - 9780128094549

SP - 231

EP - 253

BT - Type 2 Diabetes and Dementia

A2 - Srikanth, Velandai

A2 - Arvanitakis, Zoe

PB - Academic Press

CY - United Kingdom

ER -